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Abstract
Background: Nasopharyngeal carcinoma (NPC) is a type of neoplasm that is highly prevalent in East Asia and
Africa with Epstein-Barr virus (EBV), genetic, and dietary factors implicated as possible aetiologic factors. Previous
studies suggested the association of certain cytokines with the invasion and metastatic properties of NPC. The
present study examined the roles of EBV latent membrane protein-1 (LMP1), interleukin-6 (IL-6), interleukin-10
(IL-10), transforming growth factor-beta 1 (TGF-b1) and laminin in the regulation of matrix-metalloproteinases
(MMPs) and vascular endothelial growth factor (VEGF) in NPC. The effects of these factors on bmi-1, an oncogene,
and ngx6, a tumour suppressor gene, were also investigated.
Methods: TW01 cells expressing LMP1 (TW01-LMP1) were established via transfection with the B95.8 EBV LMP1
gene. Both TW01 and TW01-LMP1 cells were treated with 100 pg/ml IL-6, 1000 pg/ml IL-10 and 100 pg/ml TGF-b1,
separately and also in combination at their respective concentration for 48 hours. Treated cells were subjected to
laminin adherence assay. The cells were also cultured with and without laminin and assayed for MMP-3, MMP-9
and VEGF production using enzyme-linked immunosorbent assay (ELISA). The cellular apoptotic property was
analysed using caspase-3 apoptosis assay. The expression of bmi-1 and ngx6 gene was investigated using real time
reverse transcriptase polymerase chain reaction.
Results: LMP1 was found to reduce the adherence of NPC cells towards laminin (p < 0.05) as compared to control.
Treatment with IL-6 at 100 pg/ml enhanced the production of MMP-9 in both TW01 and TW01-LMP1 cells (p <
0.05). When cultured on laminin, the levels of MMP-3 and VEGF were significantly increased (p < 0.05) in TW01-
LMP1 cells. TW01-LMP1 cells had relatively greater resistance to apoptosis as compared to TW01 cells (p < 0.05).
Laminin, IL-6 and LMP1 were found to up-regulate the expression of bmi-1 and suppressed the expression of ngx6.
Conclusions: We conclude that IL-6 reduced cell adherence towards laminin and increased MMP-9 production in
NPC cells. Our data suggested that EBV LMP1 was able to confer resistance of apoptosis and increased MMP-9
production in NPC cells. When cultured on laminin, TW01 cells expressing the EBV LMP1 (TW0-LMP1) that were
treated with IL-6 at 100 pg/ml displayed increased MMP-9 production, up-regulation of bmi-1 oncogene expression
and down-regulation of ngx6 tumour suppressor gene expression. These findings implicate the roles of EBV LMP1,
laminin and IL-6 in the promotion of invasion and metastasis in NPC.
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Nasopharyngeal carcinoma (NPC) is a disease with an
extraordinary geographic and racial distribution world-
wide. Except for a handful of populations, NPC is a rare
human malignancy with an incidence well under 1 per
100 000 population per year, constituting less than 0.3%
of all malignant tumours and only 2% of all head and
neck cancer [1]. The most suspected etiologic factors of
NPC are genetic susceptibility, infection with Epstein-
Barr virus (EBV), and regular consumption of salted fish
beginning in childhood [2].
EBV is an ubiquitous human gamma-herpes virus that
is commonly associated with a number of malignancies
such as Burkitt’s lymphoma, Hodgkin’s disease, stomach
carcinomas and NPC [3]. NPC patients have elevated
IgG and IgA antibody titers to the EBV viral capsid anti-
gen (VCA) and to antigen associated with replication,
called early antigen (EA) [4]. Elevated expression of EBV
latent membrane protein-1 (LMP1) is correlated with
tumour progression and metastasis [5].
Until now, the treatment of cancer metastasis, includ-
ing NPC, still remain as the greatest obstacle. Laminin is
the main non-collagenous glycoprotein found in the
basement membrane. The interaction of cancer cells with
laminin was acknowledged as a key event in tumour inva-
sion and metastasis [6]. In tumours, laminin is produced
by tumour cells and also in the extracellular matrix
(ECM) [6]. According to Lee et al., LMP1 promotes
metastasis in NPC by inducing matrix metalloproteinases
(MMPs) in degrading ECM proteins [5]. MMPs have the
ability to digest a broad range of ECM molecules. These
enzymes have been implicated in the turnover of the
ECM during tumour development and progression [7].
MMP-3 expression is a prognostic indicator of invasion
and lymph node metastasis in head-and-neck squamous
cell carcinoma [8]. Subsequent study showed that a sig-
nificant level of MMP-3 was detected in NPC patients
compared with other head-and-neck cancer patients [9].
The expression of MMP-9 is positively correlated with
the expression of LMP1, as well as with the metastasis of
NPC in patients [3,10].
Vascular endothelial growth factor (VEGF) is another
important cytokine that plays an important role in
endothelial cell proliferation and the process of angiogen-
esis which are essential for tumour development [7]. In
addition, Khrishna et al. has found that expression pat-
t e r no fV E G Fc o u l db eu s e da sap o t e n t i a lt u m o u rm a r -
ker for the early diagnosis of NPC metastasis and they
showed that the upregulation of VEGF is associated with
the presence of EBV [11].
The link between inflammation and cancer has long
been recognised about 150 years ago [12,13]. It is now
becoming clear that the tumour microenvironment,
which is largely surrounded by inflammatory cells, is a
crucial participant in the neoplastic process, fostering
proliferation, survival and migration [13]. It was
reported that serum level of interleukin-6 (IL-6) was ele-
vated in NPC and prostate cancer patients [14,15].
Interestingly, interleukin-10 (IL-10) and transforming
growth factor-beta1 (TGF-b1) have been regarded as
cytokines that serve dual roles in cancer progression.
They exert anti-carcinogenic functions but play vital
roles in tumour progression [16,17]. However, the roles
of IL-6, IL-10 and TGF-b1 on the invasion and metasta-
sis on NPC are still unclear.
The present study compares the effects of IL-6, IL-10,
TGF-b1 and laminin on the biological properties of
NPC TW01 cells with and without EBV LMP1 expres-
sion. The roles of EBV LMP1, IL-6, IL-10, TGF-b1a n d
laminin in the regulation of MMPs and VEGF in NPC
were examined. The effects of these factors on bmi-1,
an oncogene, and ngx6, a tumour suppressor gene, were
also investigated.
Methods
Cell Lines
B95.8 cell is a lymphoblast-like cell line derived from
Marmoset blood lymphocytes which were exposed to
EBV from human leukocyte line. This cell line was cul-
tured in DMEM:F12 (Invitrogen, USA) supplemented
with 10% v/v fetal bovine serum (Invitrogen, USA) and
maintained in a 37°C, 5% CO2 incubator. TW01, a
human NPC cell line obtained from a 64-year old male
Taiwanese patient by Lin et al., was maintained using
the same procedure [18]. Both the TW01 and TW01-
LMP1 cell lines have been characterised by Tan et al.i n
their previous study [19].
Cloning of LMP1 gene
EBV RNA was obtained from B95.8 cells using RNeasy
Mini kit (Qiagen, USA). Reverse transcription (RT) fol-
lowed by Polymerase Chain Reaction (PCR) was per-
formed using Superscript™ III One-Step RT-PCR System
(Invitrogen, USA) according to the manufacturer’sp r o -
tocol. LMP1 gene specific primers with the forward
LMP1 sequence of 5’- CACCATGGATGGAACAC-
GACCTTGAG -3’ and reverse LMP1 sequence of 5’-
GACAGTGTGGCTAAGGGA-3’ were used at 0.2 μM
in 50 μl master mix containing 1X Reaction Mix (Invi-
trogen, USA), 1 unit RT/Platinum mix (Invitrogen,
USA), 15 μl sterile water and 1 μg of template RNA. RT
was performed at 50°C for 30 min and terminated by
incubation at 94°C for 2 min. Amplification was per-
formed using the following parameter; 94°C for 15s;
53°C for 30s and 68°C for 1 min with the final extension
of 68°C for 5 min. Amplified products were analysed by
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Page 2 of 10agarose gel electrophoresis and fragments of the correct
size (1373 base pairs) were cloned into the pcDNA3.1
Directional TOPO vector (Invitrogen, USA) according
to the manufacturer’s recommendation. The vector was
transformed into Escherichia coli for multiplication.
Proper integration of LMP1 gene into pcDNA3.1 Direc-
tional TOPO vector was confirmed by DNA sequencing
(Research Biolabs, Singapore).
Transfection of LMP1 gene into TW01 cells
LMP1-expressing TW01 cell clones were established by
transfecting the cells with pcDNA-LMP1 plasmids that
carried recombinant LMP1 gene derived from B95.8
cells. Transfection of the epithelial cells was performed
using Lipofectamine™ 2000 (Invitrogen, USA) as recom-
mended by the manufacturer. Transfected cells were
incubated for 24 h at 37°C with 5% CO2 and transgene
expressing cells were selected by passaging at 1:10 dilu-
tions in fresh selection of medium, DMEM-F12 supple-
mented with 230 μg/ml Geneticin (G418). The LMP1
protein expression was further confirmed by Western
blotting with monoclonal mouse anti-EBV LMP1 CS. 1-
4 (Dako, Denmark). TW01 expressing the LMP1 gene is
designated as TW01-LMP1. Non transfected TW01 cell
line was used as the negative reference for Western
blotting. The expression of LMP1 in the transfected
TW01 cells was also confirmed with RT-PCR using the
same procedure mentioned above.
Laminin Adhesion Assay
The relative cell attachment to laminin was assessed
using Innocyte™ ECM Cell Adhesion Assay, Laminin/
Basement Membrane Complex (Calbiochem, USA). Prior
to the assay, TW01 and TW01-LMP1 expressing cells
were treated with 100 pg/ml IL-6, 1000 pg/ml IL-10 and
100 pg/ml TGF-b1, separately and also in combination at
their respective concentrations for 48 hours. Subse-
quently, the combination treatment of IL-6 (at 100pg/
ml), IL-10 (at 1000 pg/ml), and TGF-b1 (at 100 pg/ml)
will be referred to as combined treatment in this article.
These cells were harvested and resuspended in DMEM:
F12 at the density of 400,000 cells/ml. The resuspended
cells were added into each laminin-coated well and incu-
bated at 37°C. Two hours after the initial incubation, cell
supernatant was collected and stored in -20°C for further
analyses. Each well was gently washed with phosphate
buffer saline (PBS) and Calcein-AM working solution
was added into each well and further incubated for 1 h at
37°C. Relative cell attachment on the laminin coated
wells were assessed using fluorescence plate reader at an
excitation wavelength of ~485 nm and an emission wave-
length of ~520 nm. The reaction was performed in tripli-
cates. Untreated TW01 and TW01-LMP1 cells were used
as controls.
ELISA for MMP-3, MMP-9 and VEGF
Quantitation of MMP-3, MMP-9 and VEGF protein in
the culture medium was carried out using enzyme-
linked immunosorbent assay (ELISA) (Calbiochem,
USA) as prescribed in the manufacturer’s protocol. Cul-
ture medium obtained from cells grown on laminin
treated with IL-6 (100 pg/ml), IL-10 (1000 pg/ml), TGF-
b1 (100 pg/ml) separately and also in combination at
their respective concentration for 48 h, were used. As
comparison, culture medium from cells grown without
laminin but treated with the same cytokines was used.
The reactions were performed in triplicates. Untreated
cells were served as control. Absorbance was measured
using spectrophotometric plate reader (Tecan, Switzer-
land) at dual wavelengths of 450/595 nm.
Caspase-3 Apoptosis Assay
Apoptosis of treated cells were analysed using Caspase 3
Colourimetric Assay kit (Sigma, USA) according to the
manufacturer’s recommendation. The assay is based on
the hydrolysis of the peptide substrate acetyl-Asp-Glu-
Val-Asp p-nitroanilide (Ac-DEVD-pNA) by caspase 3,
resulting in the release of p-Nitroaniline (pNA) moiety.
Apoptosis was induced in TW01 and TW01-LMP1 cells
by addition of staurosporine (Sigma, USA) to a final con-
centration of 1 μg/ml and incubated for 3 h at 37°C in a
5% CO2 atmosphere. Cells were then washed with 1 ml
P B S ,c e n t r i f u g e da n ds u s p e n d e di n1 Xl y s i sb u f f e ra ta
concentration of 10
7 cells/100 μl. Cells were incubated
on ice for 20 min before centrifugation at 20, 000 × g for
15 min at 4°C. The supernatant was collected and added
into a flat bottom 96 wells plate according to the manu-
facturer’s reaction scheme. The plate containing reaction
mixture was then covered and placed in a 37°C incubator
for 90 min. The reaction was performed in triplicates.
Results were analysed using ELISA plate reader (Tecan,
Switzerland) at the absorbance of 405 nm.
Real time quantitative RT-PCR
TW01 and TW01-LMP1 cells were treated with IL-6
(100 pg/ml), IL-10 (1000 pg/ml), TGF-b1( 1 0 0p g / m l )
for 48 hours. At the same time, another batch of cells
was treated similarly on laminin coated plates. These
cells were then harvested and total RNA was extracted
using RNeasy Mini Kit (Qiagen, USA).
Real time RT-PCR amplification was performed in an
iQ5 Cycler (Biorad, USA). Primers and TaqMan probes
for bmi-1, ngx6 and the gapdh control reference gene
were designed and synthesized according to Taqman
Gene Expression Assay (assays Hs00958696_g1,
Hs00409825_g1, and 4333764F respectively) (Applied
Biosystems, USA). PCR reactions were carried out in a
total volume of 50 μL, according the manufacturer’s
instructions. Amplification efficiency was done for all
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10-times and 100-times dilution). The reactions were
performed in triplicates.
Data Analysis
Statistical analysis was performed for the ELISA, laminin
adherence test, and apoptosis test results using Student’s
t-test.
Analysis for real time RT-PCR was performed using
the relative quantification ΔΔCt (delta delta threshold
cycle) method. Ct values were first collected from the
RT-PCR reactions. ΔCt values were then calculated with
the formula below:
Δ= Ct Ct Ct gene of interest housekeeping gene –
Next, ΔΔCt values were calculated according to the
formula:
ΔΔ Δ Δ Ct Ct test Ct reference =−
Finally, fold change was calculated using the formula:
Fold change 2
Ct =
−ΔΔ
Fold change refers to the relative fold change of the
amount of gene expressed by a particular sample of
interest compared to any chosen group of reference.
Ethics Approval
This study was approved by the International Medical
University Joint Committee on Research and Ethics in
the year 2008.
Results
Expression of LMP1 in transfected TW01 cells
Overexpression of LMP1 in LMP1-transfected TW01
cell line was confirmed using RT-PCR and western blot
analysis shown in Figures 1A and 1B. The RT-PCR pro-
duct of LMP1 from the prototype B95.8 Epstein-Barr
virus was represented by a band with the fragment size
1373 bp while in western blotting, a band of 57kDa was
detected, indicating the expression of the LMP1 protein
in transfected TW01 cells.
MMPs and VEGF production
Cell were treated with IL-6 (100 pg/ml), IL-10 (1000 pg/
ml), TGF-b1 (100 pg/ml) separately and also in combi-
nation at their respective concentration for 48h and
MMP-3, MMP-9 and VEGF produced was quantified
using ELISA.
Treatment with IL-6, IL-10, TGF-b1 individually and
in combination had no effect on the expression of
MMP-3 and VEGF in TW01 cells (Figures 2 and 3).
However, the presence of LMP1 in TW01-transfected
cells was found to significantly induce the production of
MMP-3 and VEGF in the presence of laminin (both
with the p-values < 0.05) IL-6 (100 pg/ml) was found to
significantly increase the production of MMP-9 (p <
0.05) in both TW01 and TW01-LMP1 cells when cul-
tured on laminin (Figure 4).
Resistance to apoptosis
Apoptosis was induced in TW01 and TW01-LMP1 cells
by addition of staurosporine and was analysed for acti-
vation of caspase 3. Interleukin-10 (1000 pg/ml)
enhanced apoptosis in TW01 cells but this effect was
abolished in TW01 cells expressing the EBV LMP1
(TW01-LMP1) (Figure 5). IL-6, and TGF-b1 had no sig-
nificant effects on the apoptotic index of TW01 and
TW01-LMP1 cells. However, a comparison between
TW01 and TW01-LMP1 concludes that the presence of
LMP1 alone was sufficient in conferring resistance to
apoptosis (p < 0.05) (Figure 5).
Attachment to laminin
The relative cell attachment to laminin was assessed
using the Innocyte™ ECM Cell Adhesion Assay, Lami-
nin/Basement Membrane Complex (Calbiochem, USA).
Based on cell adherence experiment (Figure 6), it was
found that TW01-LMP1 cells had lower adherence
towards laminin (p < 0.05) as compared to TW01 cells.
When treated with IL-6 (100 pg/ml), IL-10 (1000 pg/ml)
and combined treatment, cellular attachment towards
laminin was reduced in TW01 cells (p < 0.05). In
TW01-LMP1 cells, the treatment of IL-6 at 100 pg.ml
significantly reduced the cell adherence towards laminin
(p < 0.05). Treatment with TGF-b1 (100 pg/ml) showed
no effect on the adherence of both TW01 and TW01-
LMP1 cells towards laminin.
Comparison of bmi-1 and ngx6 expression in TW01 and
TW01-LMP1 cells
Expression of bmi-1 and ngx6 wsa carried out using
real-time RT-PCR amplification with gapdh as the refer-
ence gene. IL-6 (100 pg/ml) induced the up-regulation
of bmi-1 gene expression by 7.2 and 9.68-fold, respec-
tively, in TW01 cells that were cultured with and with-
out laminin. Similar observation was also noted in
TW01-LMP1 cells cultured in laminin (7.78-fold). IL-10
and TGF-b1 was found to up-regulate the bmi-1 expres-
sion in TW01-LMP1 cells (9.89-fold and 8.98-fold) cul-
tured with laminin but not in TW01 (Figure 7).
On the contrary, treatment with IL-6 (100 pg/ml) signif-
icantly down-regulated the expression of ngx6 in TW01
cells that were cultured with (0.00005061-fold) and with-
out (0.0000027-fold) of laminin. Similar observation was
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Page 4 of 10Figure 1 The overexpression of LMP1 in TW01-LMP1 cells was confirmed by RT-PCR and Western Blotting with specific antibodies.A )
The LMP1 gene was detected from the EBV LMP1-transfected by RT-PCR. B) LMP1 expression was detected as the 57 kDa protein. LMP1
represents TW01-LMP1 cell line while TW01 represents LMP1 negative TW01 cell line. TW01 served as negative control in this result.
Figure 2 The expression of MMP-3 in TW01-LMP1 and TW01 cells was measured by quantitative sandwich ELISA. Each bar represents
the mean ± SD value for assays conducted in triplicates. The term ‘Comb.’ found in the chart represents combined treatment consisting of IL-6
(100 pg/ml), IL-10 (1000 pg/ml), and TGF-b1 (100 pg/ml). The indication ‘*’ represents the significance of p < 0.05.
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Page 5 of 10Figure 3 T h ee x p r e s s i o no fV E G Fi nT W 0 1 - L M P 1a n dT W 0 1c e lls was measured by quantitative sandwich ELISA. Each bar represents
the mean ± SD value for assays conducted in triplicates. The term ‘Comb.’ found in the chart represents combined treatment consisting of IL-6
(100 pg/ml), IL-10 (1000 pg/ml), and TGF-b1 (100 pg/ml). The indication ‘*’ represents the significance of p < 0.05.
Figure 4 The expression of MMP-9 in TW01-LMP1 and TW01 cells was measured by quantitative sandwich ELISA. Each bar represents
the mean ± SD value for assays conducted in triplicates. The term ‘Comb.’ found in the chart represents combined treatment consisting of IL-6
(100 pg/ml), IL-10 (1000 pg/ml), and TGF-b1 (100 pg/ml). The indication ‘*’ represents the significance of p < 0.05.
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Page 6 of 10Figure 5 The apoptotic index of TW01 and TW01-LMP1 cells when subjected to different cytokines. The level of apoptosis was correlated to
the level of hydrolysed p-nitroaniline (pNA) measured at 405 nm. TW01-LMP1 cells were found to have reduced apoptotic index as compared to
TW01 cells. Each bar represents the mean ± SD value for assays conducted in triplicates. The term ‘Comb.’ found in the chart represents combined
treatment consisting of IL-6 (100 pg/ml), IL-10 (1000 pg/ml), and TGF-b1 (100 pg/ml). The indication ‘*’ represents the significance of p < 0.05.
Figure 6 The attachment of TW01 and TW01-LMP1 cells towards laminin after subjected to the cytokine treatments. The treatment of
IL-6 (100 pg/ml), IL-10 (1000 pg/ml), TGF-b1 (100 pg/ml), and combined treatment consisting of IL-6 (100 pg/ml), IL-10 (1000 pg/ml), and TGF-
b1 (100 pg/ml) were subjected on TW01 and TW01-LMP1 cells. Each bar represents the mean ± SD value for assays conducted in triplicates. The
term ‘Comb.’ found in the chart represents combined treatment consisting of IL-6 (100 pg/ml), IL-10 (1000 pg/ml), and TGF-b1 (100 pg/ml). The
indication ‘*’ represents the significance of p < 0.05.
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Page 7 of 10Figure 7 The fold change of bmi-1 and ngx6 expression in TW01 and TW01-LMP1 cells. A) Expression of bmi-1 and ngx6 in treated TW01
cells. B) Expression of bmi-1 and ngx6 in treated TW01-LMP1 cells. Each bar represents the mean ± SD value for assays conducted in triplicates.
The term ‘Comb.’ found in the chart represents combined treatment consisting of IL-6 (100 pg/ml), IL-10 (1000 pg/ml), and TGF-b1 (100 pg/ml).
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Page 8 of 10also noted in TW01-LMP1 cells cultured in laminin
(0.00526-fold). These observations indicated the synergis-
tic relationship between IL-6, EBV LMP1 and laminin in
up-regulating the expression of bmi-1 oncogene and
down-regulating the ngx6 tumour suppressor gene.
Discussion
Although inflammation has long been related to tissue
irritation, injury, or infection, it has recently been asso-
ciated with a wide variety of diseases including cancer.
Many studies have linked the relationship between inter-
leukins and growth factors in cancer metastasis. How-
ever, no studies have yet been done on the role of IL-6,
IL-10 and TGF-b1 in the metastasis of NPC. High levels
of MMP-3, MMP-9 and VEGF have all been associated
with metastasis in NPC and can therefore serve as end-
point measurement for metastatic disease. It was also dis-
covered that bmi-1 oncogene was up-regulated while
ngx6 tumour suppressor gene was down-regulated during
the development of tumours. Expression of bmi-1 and
ngx6 can therefore serves as an indicator for tumour
development.
The concentrations of IL-6, IL-10 and TGF-b1 used in
this study was selected based on a previous study done
by Tan et al., which reported on changes in the levels of
IL-6, IL-10 and TGF-b1 in NPC patients before and
after treatment [14].
The oncogenic properties possessed by LMP1 are
attributed to its ability to elevate anti-apoptotic proteins
and growth signals [20]. In this study, LMP1 was found
to be able to reduce the apoptosis index. TW01 cells
treated with IL-10 and TGF-b1 had increased apoptosis
index which indicate increased resistance to apoptosis.
However, when LMP1 was expressed, the effect was
abolished. This concurs with other studies which
showed that LMP1 modulate apoptosis via the NF-B
signaling pathway [21-23]. Shao et al. suggested that
LMP1 has enhanced survival and proliferation-related
signals despite heavy infliltration by lymphocytes in the
tumour cells. Our results agreed with Shao et al. that
LMP1 has the ability to prevent apoptosis by reduction
in the activity of caspase-3 [24].
VEGF is one of the most pivotal angiogenic factors
that is important for invasion and metastasis of tumour
[25,26]. LMP1 was found to up-regulate the expression
of VEGF in TW01 cells. This is consistent with a study
which indicated that VEGF expression was significantly
elevated in metastatic NPC tissues as compared to its
normal counterpart [27]. Another study also supported
our findings by reporting that VEGF has been indicated
as a marker of tumour invasion and metastasis in squa-
mous cell carcinoma of the head and neck cancer [28].
The ability of LMP1 in inducing the expression of
MMPs in NPC via its CTAR-1 and CTAR-2 regions has
been commonly reported [3,24,29-31]. This is in line
with our findings that, when cultured on laminin,
LMP1-expressing cells had enhanced MMP-3 produc-
tion. It the therefore suggested that there is possibly an
interactive role of laminin and LMP1 in the regulation
of MMP-3 expression in NPC cells.
The oncogene, bmi-1, was found to be positively cor-
related with poor prognosis in NPC patients, thus
became a valuable marker for the NPC patients [32-34].
In the presence of laminin, the expression of bmi-1 gene
was significantly up-regulated in LMP1-expressing NPC
cells. This coincided with the down-regulation of ngx6.
The gene ngx6 is a type of tumour suppressor and this
gene has been recently reported to play a role in cell
adhesion modulation in NPC [35].
Conclusion
We conclude that EBV LMP1, IL-6 and laminin have sig-
nificant roles in promoting invasion and metastasis in
NPC through increased production of MMP-9 in LMP1-
transfected TW01 cells; in addition to the up-regulation
of bmi-1 and down-regulation of ngx6.
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